AstraZeneca PLC is 161.4x more valuable than Stoke Therapeutics, Inc. by market capitalization ($286.27 B vs $1.77 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | STOK | AZN |
|---|---|---|
| Market cap | $1.77 B | $286.27 B |
| US-listed rank | #2176 | #45 |
| Revenue (latest FY) | $184.42M | - |
| Net income (latest FY) | -$6.88M | - |
| Net margin | -3.7% | - |
| SEC filings | 588 | 1,004 |
AstraZeneca PLC is 161.4x more valuable than Stoke Therapeutics, Inc. by market capitalization ($286.27 B vs $1.77 B).
Full pages: Stoke Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.